DermBiont has a total of 37 patents globally, out of which 3 have been granted. Of these 37 patents, more than 89% patents are active. The United States of America is where DermBiont has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of DermBiont.
DermBiont was founded in 2017. DermBiont is a biotechnology firm dedicated to the advancement of skin microbiome therapeutics for the treatment and prevention of various skin conditions.
Do read about some of the most popular patents of DermBiont which have been covered by us in this article and also you can find DermBiont patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over DermBiont patent portfolio.
How many patents does DermBiont have?
DermBiont has a total of 37 patents globally. These patents belong to 5 unique patent families. Out of 37 patents, 33 patents are active.
How Many Patents did DermBiont File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | DermBiont Applications Filed | DermBiont Patents Granted |
| 2023 | 1 | 1 |
| 2022 | 3 | 1 |
| 2021 | 11 | 1 |
| 2020 | 10 | – |
| 2019 | 4 | – |
| 2017 | 8 | – |
How many DermBiont patents are Alive/Dead?
Worldwide Patents
How Many Patents did DermBiont File in Different Countries?
Countries in which DermBiont Filed Patents
| Country | Patent |
| United States Of America | 6 |
| Mexico | 3 |
| Europe | 3 |
| Brazil | 3 |
| Canada | 3 |
| Australia | 3 |
| Japan | 2 |
| Singapore | 2 |
| India | 2 |
| Hong Kong (S.A.R.) | 2 |
| South Africa | 1 |
| China | 1 |
| Israel | 1 |
Where are Research Centers of DermBiont Patents Located?
The Research Centers of Derm Biont Patents is the United States of America.
What Percentage of DermBiont US Patent Applications Were Granted?
DermBiont (Excluding its subsidiaries) has filed 6 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100%.
Below are the key stats of DermBiont patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for DermBiont?
| Law Firm | Total Applications | Success Rate |
| Wilson Sonsini Goodrich & Rosati | 5 | 100% |
| Goodwin Procter Llp | 1 | 100% |
List of DermBiont patents
| DermBiont Patents | Title |
| US11040077B2 | Compositions And Methods For Improving Skin Health And For The Treatment And Prevention Of Diseases, Disorders And Conditions Associated With Pathogenic Microbes |
| US20220160617A1 | Compositions And Methods For Improving Skin Health And For The Treatment And Prevention Of Diseases, Disorders And Conditions Associated With Pathogenic Microbes |
| US20210386802A1 | Compositions And Methods For Improving Skin Health And For The Treatment And Prevention Of Diseases, Disorders And Conditions Associated With Pathogenic Microbes |
| US20210361725A1 | Compositions And Methods For Improving Skin Health And For The Treatment And Prevention Of Diseases, Disorders And Conditions Associated With Pathogenic Microbes |
| US20190388321A1 | Methods Of Treating Hyperpigmentation Disorders |
| EP4228665A1 | Compositions And Methods For Improving Skin Health And For The Treatment And Prevention Of Diseases, Disorders And Conditions Associated With Fungi And Other Pathogenic Microbes |
| EP3952848A1 | Compositions And Methods For Improving Skin Health And For The Treatment And Prevention Of Diseases, Disorders And Conditions Associated With Pathogenic Microbes |
| EP3554498A1 | Methods Of Treating Hyperpigmentation Disorders |
| CN110300584A | Methods Of Treating Hyperpigmentation Disorders |
| WO2023225373A1 | Compositions And Formulations For Use Of A Pk Inhibitor For The Prevention, Treatment, And Improvement Of Skin Diseases, Conditions, And Disorders |
| WO2023044351A1 | Compositions And Formulations For Topical Use Of An Akt Inhibitor For The Prevention, Treatment, And Improvement Of Skin Diseases, Conditions, And Disorders |
| MX393695B | Methods To Treat Hyperpigmentation Disorders. |
| BR112023006952A2 | Compositions And Methods For The Improvement Of Skin Health And For The Treatment And Prevention Of Diseases, Disorders, And Conditions Associated With Fungi And Other Pathogens |
| AU2021360828A1 | Compositions And Methods For Improving Skin Health And For The Treatment And Prevention Of Diseases, Disorders And Conditions Associated With Fungi And Other Pathogenic Microbes |
| MX2022008274A | Methods Of Treating Hyperpigmentation Disorders. |
| CA3195341A1 | Compositions And Methods For Improving Skin Health And For The Treatment And Prevention Of Diseases, Disorders And Conditions Associated With Fungi And Other Pathogenic Microbes |
| MX2021012391A | Compositions And Methods For Improving Skin Health And For The Treatment And Prevention Of Diseases, Disorders And Conditions Associated With Pathogenic Microbes. |
| BR112021020247A2 | Compositions And Methods For Improving Skin Health And For The Treatment And Prevention Of Diseases, Disorders And Diseases Associated With Pathogenic Microbes |
| AU2020271885A1 | Compositions And Methods For Improving Skin Health And For The Treatment And Prevention Of Diseases, Disorders And Conditions Associated With Pathogenic Microbes |
| CA3132858A1 | Compositions And Methods For Improving Skin Health And For The Treatment And Prevention Of Diseases, Disorders And Conditions Associated With Pathogenic Microbes |
| BR112019012383A2 | Methods Of Treatment Of Hyperpigmentation Disorders |
| AU2017382845A1 | Methods Of Treating Hyperpigmentation Disorders |
| CA3046546A1 | Methods Of Treating Hyperpigmentation Disorders |
| JP7254027B2 | Methods Of Treating Hyperpigmentation Disorders |
| SG11202302810WA | Compositions And Methods For Improving Skin Health And For The Treatment And Prevention Of Diseases, Disorders And Conditions Associated With Fungi And Other Pathogenic Microbes |
| JP2023025004A | How To Treat Hyperpigmentation Disorders |
| HK40066550A | Compositions And Methods For Improving Skin Health And For The Treatment And Prevention Of Diseases, Disorders And Conditions Associated With Pathogenic Microbes |
| IL287032A | Compositions And Methods For Improving Skin Health And For The Treatment And Prevention Of Diseases, Disorders And Conditions Associated With Pathogenic Microbes |
| SG11202111168UA | Compositions And Methods For Improving Skin Health And For The Treatment And Prevention Of Diseases, Disorders And Conditions Associated With Pathogenic Microbes |
| IN202147049977A | Compositions And Methods For Improving Skin Health And For The Treatment And Prevention Of Diseases, Disorders And Conditions Associated With Pathogenic Microbes |
| ZA202107893A | Compositions And Methods For Improving Skin Health And For The Treatment And Prevention Of Diseases, Disorders And Conditions Associated With Pathogenic Microbes |
| HK40015412A | Methods Of Treating Hyperpigmentation Disorders |
| IN201917024122A | Methods Of Treating Hyperpigmentation Disorders |
| US20180185259A1 | Methods Of Treating Hyperpigmentation Disorders |
| WO2022081762A1 | Compositions And Methods For Improving Skin Health And For The Treatment And Prevention Of Diseases, Disorders And Conditions Associated With Fungi And Other Pathogenic Microbes |
| WO2020210553A1 | Compositions And Methods For Improving Skin Health And For The Treatment And Prevention Of Diseases, Disorders And Conditions Associated With Pathogenic Microbes |
| WO2018118874A1 | Methods Of Treating Hyperpigmentation Disorders |
What are DermBiont key innovation segments?
What Technologies are Covered by DermBiont?
The chart below distributes patents filed by DermBiont